Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00229593 · ClinicalTrials.gov registry record · Phase 1
NES Gel-1, To Evaluate Nestorone Gel in Combination With Testosterone Gel
A Phase 1 study of Contraception, sponsored by University of Washington.
- Completed
- Registry status
- Phase 1
- Development phase
- 140
- Enrollment target
- 2
- Study locations
NCT00229593 is a Phase 1 study of Contraception that has completed, run by University of Washington. The registered enrollment target is 140 participants, below the 453-participant average among 72 other Contraception trials with a reported enrollment target (69% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT00229593, a Phase 1 study of Contraception, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 140 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to determine the usefulness of two transdermal gels to be used in the future development for a male contraceptive.
Conditions Studied
Interventions
- DRUG Nestorone gel
- DRUG Testosterone Gel
Study Locations (2)
California
- Harbor-UCLA Medical Center - Torrance
Washington
- University of Washington Medical Center - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2005-09 |
| Est. Completion | 2007-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00229593
The ClinicalTrials.gov registry entry for NCT00229593 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 453-participant average among 72 other Contraception trials with a reported enrollment target (69% lower). The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Contraception appearing as the primary indexed condition, and to 2 interventions - of which Nestorone gel is the first listed.
NCT00229593 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Washington.
Frequently Asked Questions
What is clinical trial NCT00229593 about?
NCT00229593 is a clinical study titled "NES Gel-1, To Evaluate Nestorone Gel in Combination With Testosterone Gel". The purpose of this study is to determine the usefulness of two transdermal gels to be used in the future development for a male contraceptive.
What is the current status of trial NCT00229593?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 140 participants. The study started on 2005-09. Estimated completion is 2007-01.
What conditions does trial NCT00229593 study?
This clinical trial studies the following conditions: Contraception.
What interventions are being tested in trial NCT00229593?
The interventions under investigation include: Nestorone gel (DRUG), Testosterone Gel (DRUG).
Who is sponsoring clinical trial NCT00229593?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00229593 being conducted?
This trial has 2 study locations across California, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Contraception
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
ORAL T-6: Oral Androgens in Man-6
COMPLETED · Phase 1
-
Pharmacokinetic and Pharmacodynamic Study of Cyclofem
COMPLETED · Phase 1
-
Study to Evaluate Suppression of Ovulation and Pharmacokinetics of Medroxyprogesterone Acetate Following Administration of TV-46046 in Women With Ovulatory Cycle
COMPLETED · Phase 1
-
A Study to Evaluate the Pharmacokinetics (PK) of Medroxyprogesterone Acetate Following an Injection of TV-46046 in Healthy Women of Reproductive Age
COMPLETED · Phase 1
-
Oral Contraceptive Pill (OCP) Pharmacogenomics
RECRUITING · Phase 4
-
Intravenous Ketorolac Administration to Attenuate Post-procedural Pain Associated With Intrauterine Device Placement
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.